CDX1
Basic information
Region (hg38): 5:150166778-150184558
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 29 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 0 | 0 |
Variants in CDX1
This is a list of pathogenic ClinVar variants found in the CDX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-150166890-A-G | not specified | Uncertain significance (Sep 03, 2024) | ||
5-150166926-C-A | not specified | Uncertain significance (Sep 25, 2023) | ||
5-150166938-C-T | not specified | Uncertain significance (May 17, 2023) | ||
5-150166968-G-T | not specified | Uncertain significance (Feb 19, 2025) | ||
5-150166988-G-C | not specified | Uncertain significance (Dec 03, 2021) | ||
5-150167016-G-C | not specified | Uncertain significance (Aug 01, 2022) | ||
5-150167046-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
5-150167092-G-C | not specified | Uncertain significance (Aug 30, 2021) | ||
5-150167121-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
5-150167186-C-T | not specified | Uncertain significance (Nov 07, 2023) | ||
5-150167195-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
5-150167223-T-A | not specified | Uncertain significance (Nov 14, 2024) | ||
5-150167303-G-A | not specified | Uncertain significance (Aug 05, 2015) | ||
5-150167306-G-A | CDX1-related disorder | Uncertain significance (Jul 31, 2023) | ||
5-150167310-G-A | not specified | Uncertain significance (Mar 14, 2023) | ||
5-150182768-G-A | not specified | Uncertain significance (Aug 07, 2023) | ||
5-150182776-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
5-150182797-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
5-150182813-A-C | not specified | Uncertain significance (Feb 27, 2025) | ||
5-150182819-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
5-150182839-T-A | not specified | Uncertain significance (Apr 09, 2024) | ||
5-150182867-G-T | not specified | Uncertain significance (Apr 20, 2023) | ||
5-150182869-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
5-150182870-G-A | not specified | Uncertain significance (Nov 09, 2024) | ||
5-150182896-G-A | not specified | Uncertain significance (Sep 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDX1 | protein_coding | protein_coding | ENST00000231656 | 3 | 17763 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.143 | 0.786 | 125418 | 0 | 2 | 125420 | 0.00000797 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0641 | 99 | 101 | 0.982 | 0.00000684 | 1613 |
Missense in Polyphen | 39 | 46.038 | 0.84713 | 691 | ||
Synonymous | 0.765 | 37 | 43.4 | 0.852 | 0.00000276 | 579 |
Loss of Function | 1.46 | 2 | 5.80 | 0.345 | 2.49e-7 | 94 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000681 | 0.0000616 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000882 | 0.00000882 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in transcriptional regulation (PubMed:24623306). Involved in activated KRAS-mediated transcriptional activation of PRKD1 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the PRKD1 promoter in colorectal cancer (CRC) cells (PubMed:24623306). Could play a role in the terminal differentiation of the intestine. Binds preferentially to methylated DNA (PubMed:28473536). {ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:28473536}.;
- Pathway
- Regulation of nuclear beta catenin signaling and target gene transcription
(Consensus)
Recessive Scores
- pRec
- 0.196
Haploinsufficiency Scores
- pHI
- 0.321
- hipred
- N
- hipred_score
- 0.424
- ghis
- 0.423
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00721
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdx1
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; embryo phenotype; pigmentation phenotype; normal phenotype; hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; skeleton phenotype;
Zebrafish Information Network
- Gene name
- cdx1b
- Affected structure
- intestinal epithelial cell
- Phenotype tag
- abnormal
- Phenotype quality
- cuboid
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;animal organ morphogenesis;anterior/posterior axis specification;anterior/posterior pattern specification;regulation of somitogenesis;cell differentiation;positive regulation of transcription by RNA polymerase II;bone morphogenesis
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;methyl-CpG binding;transcription regulatory region DNA binding